Recruiting Pompe Pregnancy Sub-Registry NCT00567073 Conditions Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +15 more Locations Barrow Neurol Group- Site Number : 840087 — Phoenix, Arizona, United States University of Florida Pediatrics Genetics- Site Number : 157138 — Jacksonville, Florida, United States Emory University School Of Medicine- Site Number : 840060 — Atlanta, Georgia, United States Indianapolis University School of Medicine- Site Number : 840027 — Indianapolis, Indiana, United States View all 35 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Exploratory Muscle Biopsy Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa NCT01288027 Conditions Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +15 more Locations Orange, California, United States Gainesville, Florida, United States Kansas City, Kansas, United States St Louis, Missouri, United States View all 15 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed High Dose or High Dose Frequency Study of Alglucosidase Alfa NCT00483379 Conditions Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +15 more Locations Birmingham, Alabama, United States Stanford, California, United States Washington D.C., District of Columbia, United States Chicago, Illinois, United States View more locations Show fewer locations Loading locations... View Trial Details
Completed Study About the Evolution of Severe Late Onset Pompe Disease Patient With Pulmonary Dysfunction and Receiving Myozyme® NCT00731081 Conditions Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +15 more Locations Pitie-Salpetriere Hospital — Paris, France View Trial Details
